Ophthalmology and Optometry Glaucoma

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Glaucoma Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Glaucoma Projects
--Alcon Inc
--Allergan Inc
--Biovitrum AB
--DAIICHI SANKYO COMPANY, LIMITED
--Gene Signal International SA
--InSite Vision Incorporated
--NicOx S.A.
--Pfizer Inc
--Santen Pharmaceutical Co., Ltd.

--Top Companies in early stage Glaucoma Projects
--Aerie Pharmaceuticals, Inc
--ACADIA Pharmaceuticals Inc
--BioAxone Therapeutic Inc.
--Allergan Inc
--Ceregene, Inc
--Cell Genesys Inc
--Inotek Pharmaceuticals, Inc
--Danube Pharmaceuticals, Inc.
--Kissei Pharmaceutical Co., Ltd.
--Inspire Pharmaceuticals Inc
--Mimetogen Pharmaceuticals Inc.
--Merck & Co Inc
--Novartis AG
--NOVAGALI PHARMA S.A
--Othera Pharmaceuticals, Inc.
--Opko Health, Inc.
--Senju Pharmaceutical Co., Ltd.
--Santen Pharmaceutical Co., Ltd.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View